Strait & Sound Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,577
Closed -$200K 152
2025
Q3
$200K Sell
2,577
-165
-6% -$12.9K 0.08% 145
2025
Q2
$214K Sell
2,742
-471
-15% -$35.1K 0.09% 137
2025
Q1
$233K Hold
3,213
0.11% 133
2024
Q4
$238K Hold
3,213
0.11% 134
2024
Q3
$212K Buy
3,213
+69
+2% +$5.01K 0.1% 136
2024
Q2
$290K Sell
3,144
-681
-18% -$60.3K 0.15% 111
2024
Q1
$350K Hold
3,825
0.2% 85
2023
Q4
$282K Hold
3,825
0.18% 99
2023
Q3
$265K Hold
3,825
0.23% 103
2023
Q2
$361K Hold
3,825
0.36% 63
2023
Q1
$316K Buy
3,825
+126
+3% +$9.9K 0.31% 76
2022
Q4
$292K Buy
+3,699
New +$285K 0.32% 76

Other funds holding EW

Strait & Sound Wealth Management's EW Position: Q4 2025 in Review

Strait & Sound Wealth Management sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 2,577 shares — an estimated $200K sold.

Strait & Sound Wealth Management first reported a position in EW in Q4 2022 and held it in 12 quarters. The position peaked at $361K in Q2 2023. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • Strait & Sound Wealth Management reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
  • Strait & Sound Wealth Management sold 2,577 Edwards Lifesciences shares in Q4 2025, an estimated $200K.
  • Strait & Sound Wealth Management first reported a position in Edwards Lifesciences in Q4 2022 and held it in 12 quarters.
  • Strait & Sound Wealth Management's Edwards Lifesciences position peaked at $361K in Q2 2023.
  • 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Strait & Sound Wealth Management's 13F filing for Q4 2025, filed 4 Feb 2026.